Highly regarded Chief Scientific Officer and medicinal chemist with extensive drug discovery experience in the pharmaceutical and biotechnology industry. Proven track record of leading drug discovery organizations, delivering preclinical, clinical candidates and approved drugs for central nervous system, oncology, infectious, liver and respiratory diseases including standalone, addition to Standard of Care, and combination drug strategies for Cystic Fibrosis (CF) including Fast Track, Orphan Status and Breakthrough Designations (FDA and EMA). Key areas of expertise: • Extensive and in-depth experience in project management, managing cross-functional drug discovery project teams, strategic planning, and mentoring. • Strong communication, leadership and interpersonal skills. • Drove working in a matrix and outsourcing environment across organizations.• Leading large teams in a global virtual drug discovery environment.• Authored over 140 publications and patents.